Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cited by (1,003)

Items 301–400 of 1,003

1. Immune responses in mildly versus critically ill COVID-19 patients
   Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, Mahsa Eshkevar Vakili, Paria Heydarinezhad, Narges Karami, Maryam Noroozi, Seppo Meri, Kurosh Kalantar · 2023 · Frontiers in Immunology
2. Enhancing host cell infection by SARS-CoV-2
   Margaret C. Kielian · 2020 · Science
3. Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells
   Jian Chen, Jun Fan, Zhilu Chen, Miaomiao Zhang, Haoran Peng, Liu Jian, Longfei Ding, Mingbin Liu, Chen Zhao, Ping Zhao et al. · 2021 · Proceedings of the National Academy of Sciences
4. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
   The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · Cardiovascular Research
5. SARS-CoV-2 Infection and Lung Regeneration
   Fuxiaonan Zhao, Qingwen Ma, Qing Yue, Huaiyong Chen · 2022 · Clinical Microbiology Reviews
6. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19
   Chisa Matsumoto, Shigeru Shibata, Takuya Kishi, Satoshi Morimoto, Masaki Mogi, Koichi I. Yamamoto, Kazuo Kobayashi, Masami Tanaka, Kei Asayama, Eiichiro Yamamoto et al. · 2022 · Hypertension Research
7. Mechanisms of SARS-CoV-2-associated anosmia
   Tatsuya Tsukahara, David H. Brann, Sandeep Robert Datta · 2023 · Physiological Reviews
8. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions
   Alize M Proust, Christophe J. Queval, Ruth Harvey, Lorin Adams, Michael Bennett, Robert John Wilkinson · 2023 · Journal of Neuroinflammation
9. Architecture of the Sema3A/PlexinA4/Neuropilin tripartite complex
   Defen Lu, Guijun Shang, Xiaojing He, Xiao‐chen Bai, Xuewu Zhang · 2021 · Nature Communications
10. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
    Daniela Ricci, Marilena Paola Etna, Fabiana Rizzo, Silvia Sandini, Martina Severa, Eliana Marina Coccia · 2021 · International Journal of Molecular Sciences
11. Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection
    Marion Ferren, Valérie Favède, Didier Décimo, Mathieu Iampietro, Nicole A. P. Lieberman, Jean‐Luc Weickert, Rodolphe Pélissier, Magalie Mazelier, Olivier Terrier, Anne Moscona et al. · 2021 · Nature Communications
12. Limited extent and consequences of pancreatic SARS-CoV-2 infection
    Verena van der Heide, S. Jangra, Phillip Cohen, Raveen Rathnasinghe, S. Aslam, T. Aydillo, D. Geanon, Diana Handler, Geoffrey Kelley, Brian Lee et al. · 2022 · Cell Reports
13. Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools
    Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone · 2024 · International Journal of Molecular Sciences
14. Histamine receptors and COVID-19
    Madeleine Ennis, Ekaterini Tiligada · 2020 · Inflammation Research
15. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
    Murat Öz, Dietrich Ernst Lorke · 2021 · Biomedicine & Pharmacotherapy
16. New-Onset Diabetes After COVID-19
    Sun H. Kim, Ipsa Arora, Daniel S. Hsia, William C. Knowler, Erin S. LeBlanc, Eleftherios E Mylonakis, Richard E. Pratley, Anastassios G. Pittas · 2023 · The Journal of Clinical Endocrinology & Metabolism
17. Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins’ Mimicry of Human Protein Interactions
    Hale Yapıcı Eser, Yunus Emre Köroğlu, Özgür Öztop Çakmak, Özlem Keskin, Attila Gürsoy, Yasemin Özdemir · 2021 · Frontiers in Human Neuroscience
18. Seroconversion stages COVID19 into distinct pathophysiological states
    Matthew D. Galbraith, Kohl T. Kinning, Kelly D. Sullivan, Ryan Michael Baxter, Paula Araya, Kimberly Rae Jordan, Seth Russell, Keith P. Smith, Ross E. Granrath, Jessica R. Shaw et al. · 2021 · eLife
19. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients
    Laksmi Wulandari, Berliana Hamidah, Cennikon Pakpahan, Nevy Shinta Damayanti, Neneng Dewi Kurniati, Christophorus Oetama Adiatmaja, Monica Rizky Wigianita, Soedarsono Soedarsono, Dominicus Husada, Damayanti Tinduh et al. · 2021 · Human Genomics
20. Cardiovascular disease in SARS‐CoV‐2 infection
    Kei Sato, Jane E. Sinclair, Habib Sadeghirad, John Francis Fraser, Kirsty Renfree Short, Arutha Kulasinghe · 2021 · Clinical & Translational Immunology
21. A mini-review on the impact of COVID 19 on vital organs
    Muhammad Dawood Shah, Aini Simon Sumeh, Muhammad Abdullah Sheraz, Muthu Subash Kavitha, Balu Alagar Venmathi Maran, Kenneth Francis Rodrigues · 2021 · Biomedicine & Pharmacotherapy
22. The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms
    Renata Kleinová, Vinod Rajendra, Alina F. Leuchtenberger, Claudio Lo Giudice, Cornelia Vesely, Utkarsh Kapoor, Andrea Tanzer A, Sophia V. Derdak, Ernesto Picardi, Michael F. Jantsch · 2023 · Nucleic Acids Research
23. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model
    Ami R. Patel, Jewell N. Walters, E. Reuschel, K. Schultheis, Elizabeth M. Parzych, E. Gary, I. Maričić, M. Purwar, Zeena Eblimit, Susanne N. Walker et al. · 2021 · Cell Reports Medicine
24. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
    Lin Wang, Ye Xiang · 2020 · Viruses
25. Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids
    Anand Ramani, Abida Islam Pranty-Weßelmann, Jay Gopalakrishnan · 2021 · Stem Cell Reports
26. Long-term evolution of the epithelial cell secretome in preclinical 3D models of the human bronchial epithelium
    Daniel Sánchez-Guzmán, Sonja Boland, Oliver Brookes, Claire Mc Cord, René Lai–Kuen, Valentina Sirri, Armelle Baeza‐Squiban, Stéphanie Devineau · 2021 · Scientific Reports
27. Mechanical activation of spike fosters SARS-CoV-2 viral infection
    Wei Hu, Yong Zhang, Panyu Fei, Tongtong Zhang, Dan Yao, Yufei Gao, Jia Liu, Hui Chen, Lu Qiao, Tenny Mudianto et al. · 2021 · Cell Research
28. Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
    E. Abebe, T. Dejenie · 2023 · Frontiers in Immunology
29. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection
    Seyed Mohammad Ali Hashemi, Marijn Thijssen, Seyed Younes Hosseini, Alijan Tabarraei, Mahmoud Reza Pourkarim, Jamal Sarvari · 2021 · Archives of Virology
30. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement
    K. Stenmark, M. Frid, E. Gerasimovskaya, Hui Zhang, M. McCarthy, J. Thurman, T. Morrison · 2021 · Pulmonary Circulation
31. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives
    Roberta Giordo, Panagiotis Paliogiannis, Arduino Aleksander Mangoni, Gianfranco Pintus · 2021 · Vascular Biology
32. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality
    Zena Wehbe, Safaa H. Hammoud, Hadi Mohamad Yassine, Manal Fardoun, Ahmed Fawzy EL‐Yazbi, Ali Hussein Eid · 2021 · Frontiers in Immunology
33. Rapid characterization of spike variants via mammalian cell surface display
    Kamyab Javanmardi, Chia‐Wei Chou, Cynthia I. Terrace, Ankur Annapareddy, Tamer Saad Kaoud, Qingqing Guo, Josh Lutgens, Hayley Zorkic, Andrew P. Horton, Elizabeth C. Gardner et al. · 2021 · Molecular Cell
34. SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability
    Fernanda Crunfli, Victor Corasolla Carregari, Flavio Protasio Veras, Pedro Henrique Vendramini, Aline Gazzola Fragnani Valença, André Saraiva Leão Marcelo Antunes, Caroline Brandão‐Teles, Giuliana S. Zuccoli, Guilherme Reis‐de‐Oliveira, Lícia C. Silva-Costa et al. · 2020 · Research Square
35. Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)
    David S. Kim, S. Rowland-Jones, E. Gea-Mallorquí · 2020 · Frontiers in Immunology
36. Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities
    Weifang Liu, Chengzhang Yang, Yuangao Liao, Feng Wan, Lijin Lin, Xuewei Huang, Binghong Zhang, Yufeng Yuan, Peng Zhang, Xiao‐Jing Zhang et al. · 2021 · Journal of Infection and Public Health
37. Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review
    Taylor J. Louis, Ahmad Qasem, Latifa S. Abdelli, Saleh A. Naser · 2022 · Microorganisms
38. Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
    Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, Mohammad Doroudian · 2022 · Reviews in Medical Virology
39. Protective neutralizing epitopes in SARS‐CoV‐2
    Hejun Liu, Ian A. Wilson · 2022 · Immunological Reviews
40. Circulating microRNAs as emerging regulators of COVID-19
    Yulong Liang, Dan Fang, Xiaojun Gao, Xin Deng, Ni Chen, Jianbo Wu, Min De ZENG, Mao Luo · 2022 · Theranostics
41. Diabetes Mellitus, Energy Metabolism, and COVID-19
    Caterina Conte, Elisa Cipponeri, Michael Roden · 2023 · Endocrine Reviews
42. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID‐19
    Brittany H. Bodnar, Kena Patel, Wen‐Zhe Ho, Jin Jun Luo, Wenhui Hu · 2020 · Journal of Medical Virology
43. Lymphoid Tissue inducer (LTi) cell ontogeny and functioning in embryo and adult
    Serge A. van de Pavert · 2020 · Biomedical Journal
44. COVID-19 as a trigger for type 1 diabetes
    Wang, Yichen, Guo, Hui, Wang, Gongquan, Zhai, Jiawei, Du, Bing · 2023 · The Journal of Clinical Endocrinology & Metabolism
45. On the road to ending the COVID-19 pandemic: Are we there yet?
    J. Case, Emma S. Winkler, J. Errico, Michael S. Diamond · 2021 · Virology
46. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
    Karthika Thankamani, Jeswin Joseph, V.R. Akshay Das, Niranjana Nair, Packirisamy Charulekha, Melvin Daniel Roji, Victor Stalin Raj · 2021 · Cells
47. Long Noncoding RNAs as Emerging Regulators of COVID-19
    Qinzhi Yang, Lin Fang, Yanan Wang, Min De ZENG, Mao Luo · 2021 · Frontiers in Immunology
48. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
    Mehdi Shahgolzari, Afagh Yavari, Yaser Arjeini, Seyed Mohammad Miri, Amirhossein Darabi, Amir Sasan Mozaffari Nejad, Mohsen Keshavarz · 2021 · Gene Reports
49. Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination
    Md. Golzar Hossain, Yan‐Dong Tang, Sharmin Akter, Chunfu Zheng · 2021 · Journal of Medical Virology
50. SARS-CoV-2 spike protein: structure, viral entry and variants
    Bing Chen, Michael Farzan, Hyeryun Choe · 2025 · Nature Reviews Microbiology
51. Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient
    Domenico Nuzzo, Gaetano Cambula, Ignazio Bacile, Manfredi Rizzo, Massimo Galia, Paola Mangiapane, Pasquale Picone, Daniela Giacomazza, Luca Scalisi · 2021 · Brain Sciences
52. Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy
    Abdi, Abdulhamid, AlOtaiby, Shahad, Badarin, Firas Al, Khraibi, Ali, Hamdan, Hamdan, Nader, Moni · 2022 · Biomedicine & Pharmacotherapy
53. Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties
    Benedikt C. Huck, Xabier Murgia, Sarah Frisch, Marius Hittinger, Alberto Hidalgo, Brigitta Loretz, Claus‐Michael Lehr · 2022 · Advanced Drug Delivery Reviews
54. Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke
    Asma W. Al-Thomali, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Michel MDW DE WAARD, Jean‐Marc Sabatier, Atif Ali Khan Khalil, ‏Hebatallah M. Saad, Gaber El‐Saber Batiha · 2022 · Biomedicines
55. ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection
    Tianhao Duan, Changsheng Xing, Junjun Chu, Xiangxue Deng, Yang Du, Xin Liu, Yuzhou Hu, Qian Chen, Bingnan Yin, Helen Y. Wang et al. · 2024 · Nature Cell Biology
56. Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection
    Samsara W. Upadhya, Jalees Rehman, Asrar B. Malik, Shuibing Chen · 2021 · Physiology
57. Small fiber neuropathy in the cornea of Covid-19 patients associated with the generation of ocular surface disease
    Alberto Barros, Juan Queiruga-Piñeiro, J. Bueno Lozano, Ignacio Alcalde, Juana Gallar, Luis Fernández-Vega-Cueto, José Fernando Alfonso, Luís M. Quirós, Jesús Merayo-Llovés · 2021 · The Ocular Surface
58. Neurological manifestations of COVID-19: a systematic review and detailed comprehension
    Zeina Hassan Ousseiran, Youssef Fares, Wafaa Takash Chamoun · 2021 · International Journal of Neuroscience
59. Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers
    Evgeny N. Knyazev, Stepan A. Nersisyan, Alexander Tonevitsky · 2021 · Frontiers in Immunology
60. Postulated Adjuvant Therapeutic Strategies for COVID-19
    Anderson Oliveira Ferreira, Hudson Caetano Polonini, Eli C. F. Dijkers · 2020 · Journal of Personalized Medicine
61. Novel compounds targeting neuropilin receptor 1 with potential to interfere with SARS-CoV-2 virus entry
    S. Perez-Miller, M. Patek, Aubin Moutal, Paz Duran, C. R. Cabel, C. Thorne, S. K. Campos, R. Khanna · 2021 · ACS Chemical Neuroscience
62. Neuropilin 1 Regulation of Vascular Permeability Signaling
    Alison Domingues, Alessandro Fantin · 2021 · Biomolecules
63. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target
    Endeshaw Chekol Abebe, Teklie Mengie Ayele, Zelalem Tilahun Muche, Tadesse Asmamaw Dejenie · 2021 · Biologics
64. Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19
    Gustavo Adolfo Argañaraz, Julys da Fonseca Palmeira, Enrique Roberto Argañaraz · 2020 · Cell Communication and Signaling
65. Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
    Farid Rahimi, Amin Talebi Bezmin Abadi · 2021 · Archives of Medical Research
66. Comparison of Cancer Patients to Non-Cancer Patients among COVID-19 Inpatients at a National Level
    Alain Bernard, Jonathan Cottenet, Philippe Bonniaud, Lionel Piroth, Patrick Arveux, Pascale Tubert‐Bitter, Catherine Quantin · 2021 · Cancers
67. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects
    Orianne Constant, Jonathan Barthelemy, Karine Bolloré, Édouard Tuaillon, Fabien Gosselet, Christine Chable-Bessia, Peggy Mérida, Delphine M. Muriaux, Philippe Van de Perre, Sara Salinas et al. · 2021 · Frontiers in Immunology
68. The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models
    Scott P Davies, Courtney J. Mycroft‐West, Isabel Pagani, Harriet J. Hill, Yen‐Hsi Chen, Richard Torbjörn Gustav Karlsson, Ieva Bagdonaite, Scott E. Guimond, Zania Stamataki, Marcelo Andrade de Lima et al. · 2021 · Frontiers in Pharmacology
69. Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells
    Weiqi Hong, Jingyun Yang, Jun Zou, Zhenfei Bi, Cai He, Lei Hong, Xuemei He, Xue Li, Aqu Alu, Wenyan Ren et al. · 2022 · Cellular and Molecular Immunology
70. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline
    Jeffrey D. Pyne, Adam M. Brickman · 2021 · Neurodegenerative Diseases
71. Neuropathic Pain in Neurologic Disorders: A Narrative Review
    Dimos Dimitrios Mitsikostas, Εleni Μoka, Enrique Orrillo, Caterina Aurilio, Athina Vadalouca, Antonella Paladini, Giustino Varrassi · 2022 · Cureus
72. Altered host protease determinants for SARS-CoV-2 Omicron
    Jasper Fuk‐Woo Chan, Xiner Huang, Bingjie Hu, Yue Chai, Hongyu Shi, Tianrenzheng Zhu, Terrence Tsz‐Tai Yuen, Yuanchen Liu, Huan Liu, Jialu Shi et al. · 2023 · Science Advances
73. Mechanisms contributing to adverse outcomes of COVID-19 in obesity
    Manu Sudhakar, Winfred Sofi Beaula, Gowri Meiyazhagan, Venkatachalam Deepa Parvathi · 2022 · Molecular and Cellular Biochemistry
74. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge
    Hongwei Li, Xue Li, Qian Wu, Xing Wang, Zhonghua Qin, Yaguo Wang, Yanbin He, Qi Wu, Li Li, Huaiyong Chen · 2022 · Cell Death and Disease
75. Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?
    Nian Xiong, Martin R. Schiller, Jingwen Li, Xiaowu Chen, Zhicheng Lin · 2021 · Alzheimer s Research & Therapy
76. Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity
    Linh T. Bui, Nichelle I. Winters, Mei-I Chung, Chitra Joseph, Austin J. Gutierrez, Arun C. Habermann, Taylor Sterling Adams, Jonas C. Schupp, Sergio Poli, Lance M. Peter et al. · 2021 · Nature Communications
77. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
    Alex J.B. Kreutzberger, Anwesha Sanyal, Ravi Ojha, Jesse D. Pyle, Olli P. Vapalahti, Giuseppe Balistreri, Tomas L. Kirchhausen · 2021 · Journal of Virology
78. COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
    Kenneth H. Lundstrom, Altijana Hromić‐Jahjefendić, Esma Bilajac, Alaa A. A. Aljabali, Katarina Baralić, Nagwa A. Sabri, Eslam Mansour Shehata, Mohamed Raslan, Ana Cláudia Barbosa Honório Ferreira, Lidiane Orlandi et al. · 2022 · Cellular Signalling
79. Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
    Guoli Shi, Tiansheng Li, Kin Kui Lai, Reed F. Johnson, Jonathan Wilson Yewdell, Alex A. Compton · 2024 · Nature Communications
80. Human transferrin receptor can mediate SARS-CoV-2 infection
    Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zilei Duan, Lei Liu, Shuaiyao Lu, Lei Ma, Ruomei Cheng, Wang Gan et al. · 2024 · Proceedings of the National Academy of Sciences
81. Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
    Mengfei Chen, Andrew S Pekosz, Jason Villano, Wenjuan Shen, Ruifeng Zhou, Heather M. Kulaga, Zhexuan Li, Amy K. Smith, Asiana Gurung, Sarah E. Beck et al. · 2024 · Journal of Clinical Investigation
82. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus
    Yuji Kondo, Jason L. Larabee, Liang Gao, Huiping Shi, Bojing Shao, Christopher Hoover, J. Michael McDaniel, Yen‐Chun Ho, Robert Silasi‐Mansat, Stephanie A. Archer‐Hartmann et al. · 2021 · JCI Insight
83. SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner
    Yun-Qi Zhou, Ke Wang, Xueyan Wang, Hong‐Yong Cui, Yongxiang Zhao, Ping Zhu, Zhi‐Nan Chen · 2022 · Emerging Microbes & Infections
84. Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish
    Aurora Kraus, Mar Huertas, Laura V. Ellis, Pierre Boudinot, Jean‐Pierre Levraud, Irene Salinas · 2022 · Brain Behavior and Immunity
85. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
    Geidy E. Serrano, Jessica E. Walker, Cécilia Tremblay, Ignazio Stefano Piras, Matthew J. Huentelman, Christine M. Belden, Danielle Goldfarb, David Shprecher, Alireza Atri, Charles H. Adler et al. · 2022 · Journal of Neuropathology & Experimental Neurology
86. Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains
    Sarah M. Roelle, Nidhi Shukla, Anh T. Pham, Anna M. Bruchez, Kenneth A. Matreyek · 2022 · PLoS Biology
87. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
    Wagner, Julian U. G., Bojkova, Denisa, Shumliakivska, Mariana, Luxán, Guillermo, Nicin, Luka, Aslan, Galip S., Milting, Hendrik, Kandler, Joshua D., Dendorfer, Andreas, Heumueller, Andreas W. et al. · 2021 · Basic Research in Cardiology
88. Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets
    Max Maurin, Florence Fenollar, Oleg Mediannikov, Bernard Davoust, Christian Albert Devaux, Didier Raoult · 2021 · Microorganisms
89. Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
    Christian Albert Devaux, Lucile Pinault, Ikram Omar Osman, Didier Raoult · 2021 · Frontiers in Public Health
90. Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19
    Ranjana Bhandari, Garima Khanna, Dhriti Kaushik, Anurag Kuhad · 2021 · Molecular Neurobiology
91. COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart
    Maurizio Pesce, Piergiuseppe Agostoni, Hans Erik Bøtker, Bianca J.J.M. Brundel, Sean M. Davidson, Raffaele De Caterina, Péter Ferdinandy, Henrique Girão, Mariann Gyöngyösi, Jean‐Sébastien Hulot et al. · 2021 · Cardiovascular Research
92. HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19
    Liqun Zhang, Santosh K. Ghosh, Shrikanth Chomanahalli Basavarajappa, Yinghua Chen, Pravesh Shrestha, Jackson Penfield, Ann Brewer, Parameswaran Ramakrishnan, Matthias Buck, Aaron Weinberg · 2022 · iScience
93. The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3
    John T. Schroeder, Anja P. Bieneman · 2022 · Frontiers in Immunology
94. Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
    Taif Shah, Zahir Shah, Nafeesa Yasmeen, Zulqarnain Baloch, Xueshan Xia · 2022 · Frontiers in Immunology
95. Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
    Zhenfeng Wang, Shunshun Li, Bo Huang · 2022 · Signal Transduction and Targeted Therapy
96. Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein
    Kailu Yang, Chuchu Wang, Alex J.B. Kreutzberger, Ravi Ojha, Suvi H. Kuivanen, Sergio Couoh‐Cardel, Serena Muratcioğlu, Timothy J. Eisen, K. Ian White, Richard G. Held et al. · 2022 · Proceedings of the National Academy of Sciences
97. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
    Jesús Porta-Etessam, Ivan Javier Nuñez-Gil, Nuria González García, Cristina Fernández, María Carmen Viana-Llamas, Charbel Maroun‐Eid, Rodolfo Romero, María Molina, Aitor Uribarri, Víctor Manuel Becerra‐Muñoz et al. · 2021 · Infection
98. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage
    Ya Wen Cheng, Tai‐Ling Chao, Chiao‐Ling Li, Sheng-Han Wang, Han‐Chieh Kao, Ya‐Min Tsai, Hurng‐Yi Wang, Chi-Ling Hsieh, You-Yu Lin, Pei‐Jer Chen et al. · 2021 · mBio
99. Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution
    Christian Albert Devaux, Lucile Pinault, Jérémy Delerce, Didier Raoult, Anthony Levasseur, Roger Frutos · 2021 · Frontiers in Microbiology
100. Nasally inhaled therapeutics and vaccination for COVID‐19: Developments and challenges
     Jinxiang Xi, Lameng Ray Lei, William Zouzas, Xiuhua April Si · 2021 · MedComm